Let’s talk about #4Pmedicine approach in CVD at the #ESCCongress! In just one week, we will be joining the biggest and the leading cardiology congress in Europe. Our Trustee and Chair of the Policy and Innovationa Advisory Committee, Marius Geanta, MD will be there too. Connect with him to discuss ideas around the implementation of 4P Medicine in the context of Lp(a), FH and inherited CVD risk factors. Along the European ambition for a CVH Plan, innovation and data- 4P Medicine brings all those elects together. And this is why we want to champion it with the FH Europe Foundation community! 4P medicine - personalized, preventive, predictive, and participatory - offers a more global vision of personalized medicine. It is intended to transform the management of health, disease and medical practices.
President of AVEC, a patient advocacy and support group - Patient Advocacy - Patient Partner - Practitioner in Educational Therapy for Patients
1yWill be there, let's chat over a coffee at WHF booth